- Home
- SNPX vs PAPL Comparison
SNPX vs PAPL Comparison
Compare SNPX & PAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNPX
- PAPL
- Stock Information
- Founded
- SNPX 2012
- PAPL 2015
- Country
- SNPX United States
- PAPL Canada
- Employees
- SNPX N/A
- PAPL N/A
- Industry
- SNPX Medicinal Chemicals and Botanical Products
- PAPL Finance: Consumer Services
- Sector
- SNPX Health Care
- PAPL Finance
- Exchange
- SNPX Nasdaq
- PAPL Nasdaq
- Market Cap
- SNPX 3.1M
- PAPL 2.5M
- IPO Year
- SNPX N/A
- PAPL 2023
- Fundamental
- Price
- SNPX $2.12
- PAPL $0.29
- Analyst Decision
- SNPX Strong Buy
- PAPL Strong Buy
- Analyst Count
- SNPX 1
- PAPL 2
- Target Price
- SNPX $14.00
- PAPL $5.25
- AVG Volume (30 Days)
- SNPX 11.9K
- PAPL 54.5K
- Earning Date
- SNPX 05-14-2025
- PAPL 04-14-2025
- Dividend Yield
- SNPX N/A
- PAPL N/A
- EPS Growth
- SNPX N/A
- PAPL N/A
- EPS
- SNPX N/A
- PAPL N/A
- Revenue
- SNPX N/A
- PAPL $2,848,365.00
- Revenue This Year
- SNPX N/A
- PAPL $22.95
- Revenue Next Year
- SNPX N/A
- PAPL $29.98
- P/E Ratio
- SNPX N/A
- PAPL N/A
- Revenue Growth
- SNPX N/A
- PAPL 13.01
- 52 Week Low
- SNPX $1.84
- PAPL $0.18
- 52 Week High
- SNPX $5.38
- PAPL $2.14
- Technical
- Relative Strength Index (RSI)
- SNPX 37.61
- PAPL 43.64
- Support Level
- SNPX $1.93
- PAPL $0.25
- Resistance Level
- SNPX $2.29
- PAPL $0.31
- Average True Range (ATR)
- SNPX 0.18
- PAPL 0.03
- MACD
- SNPX 0.01
- PAPL 0.00
- Stochastic Oscillator
- SNPX 39.63
- PAPL 52.78
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.